BiotechTube
Home/Alzamend Neuro/Lynne Fahey McGrath
LF

Lynne Fahey McGrath

Board Director

Alzamend Neuro

Therapeutic Areas

Alzheimer's DiseaseBipolar DisorderMajor Depressive DisorderPost-Traumatic Stress Disorder

Alzamend Neuro Pipeline

DrugIndicationPhase
AL001Bipolar DisorderPhase II
ALZN002Alzheimer's DiseasePreclinical

Leadership Team at Alzamend Neuro

SJ
Stephan Jackman
Founder/CEO
AH
Andrew H. Woo
Board Director
MG
Mark Gustafson
Board Director, Audit Committee Chair
JO
Jeffrey Oram
Board Director
TM
Thomas M. Wisniewski
Scientific Advisor
EM
Eric M. McDade
Scientific Advisor
TH
Terri Hunter
Technology Transfer Advisor
View full Alzamend Neuro profile